Cigna Ventures

At the foundation of each of our investments is a commitment to helping our portfolio companies grow so they can better serve employers of all size. Employers make significant investments to make health care more accessible and easier to navigate. Our portfolio companies bring innovations to market that meet some of employers’ most pressing health care needs, including care navigation, advanced primary care, fertility planning and advanced analytics. Here are some of our current key areas of focus: Drug Management: Prices for drugs – particularly in high-cost categories like oncology, obesity and cell gene therapy – are outpacing inflation. We seek investment opportunities that address drug spend and access, with a specific focus on high-cost drugs or conditions that are highly prevalent in employer-sponsored insurance populations. Data and Analytics: Employers need solutions that make the vast amount of available health care data actionable and tailored to their insured populations. As such, we consider investment opportunities that provide the necessary infrastructure and analytic capabilities to impact administrative efficiency or drive improvements in health care quality and price transparency. Small- and Medium-Sized Business (SMB) Solutions: Rising health care costs place a severe burden on SMBs. In fact, the smallest employers are facing the biggest hikes in premium costs. Employers with just 1-10 employees saw a 12% increase in average family plan premiums in 2022. To help navigate this challenge, we weigh investment opportunities that enable SMBs to provide more affordable, high-quality, and equitable health care to employees through new purchasing and coverage models. Behavioral Health: Fragmented solutions have proven ineffective in addressing the behavioral health needs of patients. To help drive change in this area, we’re considering investment opportunities that approach patient care holistically, with behavioral and medical spend linked to create a comprehensive and unified view of the patient. Women’s Health: Despite deep investments in this area from employers, too many gaps in health and access to care still exist. There are opportunities to solve for the discrete, largely unmet, needs of women in the workforce, including but not limited to maternity, menopause, and comprehensive women’s primary care.

SCOR Ventures is the venture investment arm of SCOR Reinsurance, responsible for both investing in and creating partnerships with startups across the insurtech landscape. Since 2017 we have built a global portfolio across three theses: (1) investing in tech-driven underwriting companies (MGAs, carriers) and distributors, (2) software solutions that benefit SCOR and/or our clients, and (3) companies that help people live healthier lives. Our investment scope includes both investments and commercial (re)insurance relationships with startups. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. What we’re looking for We invest across three thesis areas: Thesis 1: we invest and partner in the ‘Insurers of the Future’: tech-driven underwriting companies (MGAs, carriers) that offer multiple points of digital and business model differentiation across P&C and L&H. We provide direct access to SCOR expertise and our global network to help portfolio companies scale and/or access (re)insurance capacity. With a proven track record of supporting innovative underwriting propositions across multiple lines of business, we understand product development, program structuring, underwriting, pricing and distribution and thus have the capabilities to optimise partnerships between insurtechs and business partners. We predominantly invest at late Seed / Series A. We are class of business agnostic and have partnered with companies across a broad variety of personal and specialty lines. Thesis 2: we invest and partner in software solutions that benefit SCOR and/or our clients. We provide a broad understanding of the interests and pain points of insurers across the world, and the potential to connect companies with insurers through SCOR’s client services initiatives. We predominantly invest later stage vs. Thesis 1 (typically Series A-B) but have occasional appetite for Seed. We prioritise companies: developing data, tools, and methods for obtaining, understanding, pricing and transferring large portfolios of pre-aggregated risks, high-value individual risks such as energy facilities and construction mega-projects, and MGA/coverholder business delivering economically valuable additional services offering a visible outcome which can be used to boost client management or reduce risks. Focus areas include front-end (e.g., underwriting & pricing) policy administration, modelling, risk analytics, and claims developing platforms where insurance has not previously been embedded / distributed, but where SCOR Ventures sees substantial opportunities to close the global protection gap – e.g., marketplaces, “super apps”, b2b fintech, employee benefits working to solve climate and ESG challenges to support the net zero transition and cut emissions for SCOR and SCOR clients. Focus areas include ESG reporting, climate risk analysis and data, carbon offsetting as a solution, circular economy, diversity, equity, and inclusion (DEI) tech, and supply chain transparency. We also see several opportunities in the green insurance product space including solar production or maintenance guarantees, wind input parametric products, solar physical asset damage, cat-bond / ILS and insuring carbon credit projects. Thesis 3: We invest at the intersection of health and technology and partner with companies that help people live healthier lives, deliver in-force or claims outcome improvements, develop new business or add to SCOR’s Knowledge Center capabilities, and assist our clients to transform their offerings. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. How we operateIntegrated in the wider SCOR business: Direct access to the entirety of SCOR’s capabilities brings unique added value to our portfolio companies. SCOR’s core business has experts in nearly every country, line of business, and functional area, while SCOR Partners bring a broad range of client services, marketing and product development expertise. Mandate: focused on key markets in North America, EMEA and LATAM, with selective deployment in APAC and Africa. Stage and ownership: We invest Seed to Series B. We typically seek greater than 5% ownership at first investment, which may include a board seat (we have led or co-led half of our investments to date). Our investment is intended to make SCOR a meaningful contributor but leave founders room to manage their cap table. We look for a long-term investment and / or commercial relationship but do not seek a fast exit or to ultimately acquire portfolio companies. Partnership approach: we are active supporters of the companies we work with, assisting with technical input, recruitment, capital optimisation and more. The material growth of many insurtech MGAs and carriers has led to increasing demand for (re)insurance capacity; SCOR is a transparent, long-term partner. Insurtechs in SaaS and services segments, meanwhile, have benefited from SCOR’s long-standing client relationships, while SCOR benefits from bringing knowledge, links, and expertise regarding services with genuine value to our clients. We bring value to our portfolio companies by connecting them with other partner companies, as well as with founders and distribution leads in our network. Why partner with SCOR VenturesWe believe in fewer, deeper relationships over the long term. We are flexible and collaborative in our approach, tailoring a solution to your specific needs, in partnership with other insurers, reinsurers, and investors involved in your company as appropriate. We underwrite most major lines of business and geographies globally. We have a global network including insurance licenses but not a competing retail insurance arm. Insurers are our clients, so working with us does not limit your options to associate with insurers. In selected circumstances, we can offer access to Lloyd’s or SCOR’s insurance licenses in the U.S., Europe, Asia, Brazil, South Africa, and other markets. We look to move quickly with direct access to decision makers, whilst leveraging resources and expertise to ensure our partners can build relationships with the appropriate parts of our organization.

Tickets a partir de R$10 milhões, com participações minoritárias em rounds a partir de Series A. Objetivo do Fundo O Kinea Ventures é um fundo de venture capital focado em investimentos em startups inovadoras do mercado de serviços financeiros e de tecnologia. Como gestores da iniciativa de Corporate Venture Capital do Grupo Itaú Unibanco, buscamos impulsionar empreendedores e suas startups que estão transformando seus mercados através de conexão e colaboração com o ecossistema de inovação. Tese de Investimentos Investimos em startups a partir do estágio Series A, adquirindo participações minoritárias em empresas que tenham sinergia potencial com o Itaú Unibanco e que ao mesmo tempo mantenham sua independência. Nossa tese envolve 3 frentes: – Fintechs, como serviços financeiros, meios de pagamentos, wealth management, mercado de capitais, BFM, PFM, seguros, dentre outros, que vislumbrem mudanças relevantes no sistema financeiro e abertura de novos mercados; – Tecnologias voltadas a setores específicos: agtech, edtechs, healthtechs, HRtechs, lawtechs, entre outros, e que possam contribuir de alguma forma com o setor financeiro; – Enablers de tecnologia: como big data & analytics, inteligência artificial, produtividade, automação, que tenham capacidade de alavancagem de receitas e redução de custos. Proposta de valor Como Kinea, buscamos trazer as melhores práticas de mercado, podendo nos associar a outros investidores nos rounds em que participamos, auxiliando nossas investidas a expandirem seus negócios com sucesso e aprimorarem sua governança. Como Grupo Itaú Unibanco, o fundo é uma das formas encontradas pelo Itaú para se manter próximo do ecossistema de empresas inovadoras que atuam em segmentos estratégicos para o banco, o que é vital em um meio ambiente altamente disruptivo. Os investimentos são realizados por meio do Kinea Ventures, gerido pela Kinea, de forma a criar parcerias entre o banco e as companhias, preservando a sua independência e contribuindo para alavancá-las e acelerar seu crescimento.

Rhia Ventures’ mission is to create a vibrant US market for sexual, reproductive, and maternal health that produces equitable outcomes for all. This multi-billion dollar market has tremendous potential for public health impact, but it has been built on flawed systems that perpetuate unjust outcomes for women of color, low-income women, and others directly affected by systemic inequities. Our work is to transform this market. We know that transformation happens when partners with long experience in reproductive health and justice come together with market-facing actors to create deep, meaningful impact. By connecting activists, public health professionals, scientists, entrepreneurs, corporates, and investors, together we will build a more just marketplace. Rhia is enabling this change through four complementary efforts: We make direct investments in early- and growth-stage companies that are driving innovation, access, and equity in reproductive and maternal health, through our wholly owned venture fund, RH Capital Corporation. We provide technical assistance and shared resources to these companies and others so that they can strengthen their work in health equity and spur change across the venture ecosystem. We work through our Corporate Engagement and Blossom programs to change social norms, practices, and people that influence this market. We produce a systems-change assessment of the market, identifying the key leverage points for addressing systemic racism and other inequities to inform Rhia’s programs and share with grant-makers, investors, and policy-makers seeking to “make this market work for justice,” to paraphrase Darren Walker of the Ford Foundation. Our Vision for Success Alongside our partners, our efforts will: Catalyze investment in innovation that improves equity, access, and outcomes in reproductive and maternal health care Transform systems in the reproductive and maternal health market, to redress systemic inequity and contributes to improving reproductive and maternal health outcomes for women of color, low-income women, and others directly affected by systemic inequities Amplify the perspectives and work of stakeholders of color Strengthen social norms, to support high-quality maternal and reproductive health care for all women and birthing people in the US